Annexon, Inc. — Investor Relations & Filings
Annexon, Inc. is a clinical-stage biopharmaceutical company developing a new class of complement medicines. The company's therapeutic approach is centered on inhibiting C1q, the initiating molecule of the classical complement pathway. By blocking C1q at the start of this immune cascade, Annexon aims to prevent the inflammation and tissue damage that drive a range of diseases. Its pipeline is focused on developing treatments for classical complement-mediated disorders affecting the body, brain, and eye, which include autoimmune, neurodegenerative, and ophthalmic conditions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| SCHEDULE 13G/A - Annexon, Inc. (0001528115) (Subject) | 2026-03-26 | English | |
| 4 - ANNEXON, INC. (0001528115) (Filer) | 2026-03-04 | English | |
| 4 - ANNEXON, INC. (0001528115) (Filer) | 2026-03-04 | English | |
| 4 - ANNEXON, INC. (0001528115) (Filer) | 2026-03-04 | English | |
| 4 - ANNEXON, INC. (0001528115) (Filer) | 2026-03-04 | English | |
| 4 - ANNEXON, INC. (0001528115) (Filer) | 2026-03-04 | English |
Browse filings by year
10 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
BIOCRYST PHARMACEUTICALS INC
Develops novel medicines for patients with rare and serious…
|
BCRX | US | Manufacturing |
|
Biocure Technology Inc.
Develops and commercializes advanced biological medicines, …
|
CURE.X | CA | Manufacturing |
|
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Develops novel antibody-based drugs and provides integrated…
|
2315 | HK | Manufacturing |
|
Biodexa Pharmaceuticals Plc
Clinical-stage biopharma developing treatments for rare dis…
|
BDRX | GB | Manufacturing |
|
BioDlink International Company Limited
Integrated biopharmaceutical CDMO specializing in ADC platf…
|
1875 | HK | Manufacturing |
|
BioEnvelop Technologies Corporation
Developed rapidly dissolving edible film strips for nutrace…
|
BIE | CA | Manufacturing |
|
Biofarm S.A.
A pharmaceutical company that manufactures and markets medi…
|
BIO | RO | Manufacturing |
|
BIO-FD&C CO.,LTD.
Develops active ingredients for cosmetics and pharma using …
|
251120 | KR | Manufacturing |
|
Biofil Chemicals & Pharmaceuticals
Produces pharmaceutical formulations, bulk drugs, and plast…
|
BIOFILCHEM | IN | Manufacturing |
|
Biofrontera AG
Biopharmaceutical firm specializing in photodynamic therapy…
|
B8F | DE | Manufacturing |
Annexon, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33181/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33181 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33181 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33181 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33181}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Annexon, Inc. (id: 33181)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.